See also this year's filing and all EDGAR filings for this company.
PDF Report 0001433714_2017_Castlight_Health_INC.pdf
Logs
| warning | The EntityCommonStockSharesOutstanding does not exist | industry.us_generic | {} |
| warning | No LiabilitiesAndStockholdersEquity node found | input.sec.calculation_linkbase.edgar_model_mapping | {'lase_node': None, 'equity_node': None, 'partners_cap_node': None, 'nodes': "NodeView(('AssetsCurrent', 'Assets', 'PropertyPlantAndEquipmentNet', 'AvailableForSaleSecuritiesNoncurrent', 'RestrictedCashAndCashEquivalentsNoncurrent', 'DeferredSalesCommissionsNoncurrent', 'OtherAssetsNoncurrent', 'CashAndCashEquivalentsAtCarryingValue', 'AvailableForSaleSecuritiesCurrent', 'AccountsReceivableNetCurrent', 'DeferredSalesCommissionsCurrent', 'PrepaidExpenseAndOtherAssetsCurrent', 'LiabilitiesCurrent', 'Liabilities', 'DeferredRevenueNoncurrent', 'OtherLiabilitiesNoncurrent', 'AccountsPayableCurrent', 'AccruedLiabilitiesandOtherAccruedLiabilitiesCurrent', 'EmployeeRelatedLiabilitiesCurrent', 'DeferredRevenueCurrent'))"} |
| warning | Large missing amount for aggregate "Expenses" added to remainder. | industry.us_generic | {'missing_ratio': 0.7478128337753669, 'aggregate_val': 145640000, 'exp_sum': 83327000, 'exp_to_value': {'CostOfGoodsAndServicesSold': 0, 'SellingExpense': 0, 'GeneralAndAdministrativeExpense': 28825000, 'ResearchAndDevelopment': 54502000, 'DepreciationDepletionAndAmortization': 0, 'remainder_Expenses': 0}} |
| info | Failed to set obs_EconomicCapitalRatio | industry.us_generic | {'reason': "KeyError('EntityCommonStockSharesOutstanding')"} |
| info | Added remainder_ComprehensiveNetIncome directly from 10K | industry.us_generic | {} |
Graph
Absolute values for 0001433714, Castlight Health INC
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 141,010,000 |
| 1 | AssetsNonCurrent | 9,962,000 |
| 2 | IntangibleAssets | 0 |
| 3 | remainder_Assets | 6,194,000 |
| 4 | LiabilitiesCurrent | 53,968,000 |
| 5 | LiabilitiesNonCurrent | 1,236,000 |
| 6 | remainder_Liabilities | 0 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingExpense | 58,800,000 |
| 9 | GeneralAndAdministrativeExpense | 26,859,000 |
| 10 | ResearchAndDevelopment | 40,460,000 |
| 11 | DepreciationDepletionAndAmortization | 0 |
| 12 | remainder_Expenses | 0 |
| 13 | remainder_Revenues | 0 |
| 14 | remainder_NetIncome | 67,571,000 |
| 15 | remainder_ComprehensiveNetIncome | 79,000 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 157,166,000 |
| 1 | Liabilities | 55,204,000 |
| 2 | Expenses | 126,119,000 |
| 3 | Revenues | 0 |
| 4 | StockholdersEquity | 101,962,000 |
| 5 | NetIncome | -58,548,000 |
| 6 | ComprehensiveNetIncome | -58,469,000 |
| 7 | BaseVar | 251,511,750 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | 0.624 |
| 9 | EconomicCapitalRatio | 2.14 |